Evidence map›Paper›PMID 17598055›Full record

ArticleSocial psychiatry and psychiatric epidemiology2007

Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany.

Anke Bramesfeld, Thomas Grobe, Friedrich Wilhelm Schwartz

Abstract read
PubMed Publisher
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Screening for depression in the older long-term unemployed.Social psychiatry and psychiatric epidemiology · 2009
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anke BramesfeldDept. for Epidemiology, Social Medicine, and Health System Research, Medical School Hannover, OE 5410, Carl Neunberg Strasse 1, 30625, Hannover, Germany. bramesfeld.a@mh-hannover.de
Thomas Grobe
Friedrich Wilhelm Schwartz
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies on the treatment of depression using epidemiological survey methods suggest a high level of under-treatment. Little is known about the characteristics of those people receiving treatment and indeed what kind of treatment they are likely to receive.

methodAnalysis of the data of a statutory health insurance company in Germany.

resultsIn middle-aged groups, about 50% of those diagnosed as being depressed in outpatient care are prescribed antidepressants and/or psychotherapy in the course of a year. There is more pharmacologic treatment provided in rural areas and more psychotherapy in cities, suggesting that treatment is dependent upon service availability rather than evidence-based treatment decisions. Treatment rates are considerably lower in the very young and the very old and show gender bias. Young females receive less pharmacologic treatment than young males, and elderly men are, in general, treated less than women, suggesting under-treatment at least for these groups.

conclusionsThe low treatment rates following the diagnosis of depression in the young and the old require attention, in particular with respect to gender aspect.

Indexed as

National Health ProgramsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolDepressive DisorderFemaleGermanyHumansInsurance, PsychiatricMaleMental Health ServicesMiddle AgedSurveys and Questionnaires

Identifiers

PMID17598055
OpenAlexW1595197381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.